Last reviewed · How we verify
Trimetazidine As a Potential Adjuvant Therapy in Acute Aluminum Phosphide Poisoning-induced Cardiotoxicity: A Randomized Controlled Clinical Trial
The aim of the present study is to evaluate the potential adjuvant therapeutic effect of trimetazidine in treatment of acute AlP poisoning-induced cardiotoxicity.
Details
| Lead sponsor | Tanta University |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 40 |
| Start date | 2021-02 |
| Completion | 2021-07 |
Conditions
- Aluminum Phosphide Poisoning
Interventions
- standard treatment
- trimetazidine hydrochloride "metacardia" ® 20 mg tablet
Primary outcomes
- Mortality — 7 days
mortality rate